Patents Assigned to Diopsys, Inc.
-
Patent number: 11185276Abstract: A method and a system are disclosed for extracting important signal information. The method examines a group of signals obtained from testing of a patient's nervous system and finds a signal area of interest. Once a cluster of signals that all have the area of interest is found—the system concludes that the area of interest is located and validated. Signals that are not within the cluster are rejected and the signals within the cluster are signal-averaged to yield a signal-averaged waveform. The signal averaged waveform represents the results of the test.Type: GrantFiled: June 28, 2017Date of Patent: November 30, 2021Assignee: DIOPSYS, INC.Inventor: Laurie A. Cox
-
Patent number: 9717465Abstract: A method and system for extracting important signal information is disclosed. The method examines a group of signals obtained from testing of a patient's nervous system and finds a signal area of interest. Once a cluster of signals that all have the area of interest is found—the system concludes that the area of interest is located and validated. Signals that are not within the cluster are rejected and the signals within the cluster are signal-averaged to yield a signal-averaged waveform. The signal averaged waveform represents the results of the test.Type: GrantFiled: July 22, 2013Date of Patent: August 1, 2017Assignee: Diopsys, Inc.Inventor: Laurie A. Cox
-
Patent number: 9367915Abstract: A method of analyzing an OCT image. An OCT image has many differently colored dots. The system detects the number of differently colored dots, quantifies them and performs statistical analyses to determine a likelihood of disease. The different colored dots correspond to different retina cell types and structures.Type: GrantFiled: July 22, 2014Date of Patent: June 14, 2016Assignee: Diopsys, Inc.Inventors: Peter Derr, Alberto Gonzalez, Laurie Cox
-
Patent number: 9026189Abstract: A multilayer electrode sensor assembly for electroretinography and pattern electroretinography formed as a thin strip to fit under a lower eyelid and contain an electrode in line with the pupil of an eye with signals detected carried through an integrally formed thin conductive strip to a terminal to be connected to an electrical conductor for carrying such signals to an analyzer.Type: GrantFiled: November 16, 2012Date of Patent: May 5, 2015Assignee: Diopsys, Inc.Inventors: Alberto Gonzalez Garcia, Donald E. Lepone
-
Patent number: 8787645Abstract: A method of analyzing an OCT image. An OCT image has many differently colored dots. The system detects the number of differently colored dots, quantifies them and performs statistical analysis to determine a likelihood of disease. The different colored dots correspond to different retina cell types and structures.Type: GrantFiled: July 21, 2011Date of Patent: July 22, 2014Assignee: Diopsys, Inc.Inventors: Peter Derr, Alberto Gonzalez, Laurie Cox
-
Publication number: 20140024964Abstract: A method and system for extracting important signal information is disclosed. The method examines a group of signals obtained from testing of a patient's nervous system and finds a signal area of interest. Once a cluster of signals that all have the area of interest is found—the system concludes that the area of interest is located and validated. Signals that are not within the cluster are rejected and the signals within the cluster are signal-averaged to yield a signal-averaged waveform. The signal averaged waveform represents the results of the test.Type: ApplicationFiled: July 22, 2013Publication date: January 23, 2014Applicant: DIOPSYS, INC.Inventor: Laurie A. Cox
-
Patent number: 8100533Abstract: A pattern VEP system for screening for glaucoma and other optic nerve related diseases/deficiencies. The system combines high contrast and low contrast testing. The low contrast testing allows for highly sensitive glaucoma testing and the high contrast allows for a sensitive test of the central vision. The system also includes a narrowly tailored method of rejecting corrupted data allowing the system to selectively salvage useful portions of a signal. The system also provides a method of data modeling to locate the N75-P100-N135 complex in a waveform and determine if it falls within the normal range.Type: GrantFiled: May 5, 2009Date of Patent: January 24, 2012Assignee: Diopsys, Inc.Inventors: Peter H. Derr, Matt Emmer
-
Patent number: 8083354Abstract: A method for determining a likelihood of a visual deficit in a subject uses a simultaneously multi-temporal visual test. At least two visual patterns are simultaneously displayed to the subject. Each pattern reverses in contrast or color at a different display frequency, and each pattern is displayed to a different region of the subject's visual field. Electrical activity of the brain of the subject is captured and sampled, and one or more frequency components are resolved from the resulting signal, where each frequency component corresponds to a different display frequency. The method then involves determining from the frequency components, optionally by comparison between the eyes, a measurement of a likelihood that a visual deficit exists in a particular area.Type: GrantFiled: October 3, 2007Date of Patent: December 27, 2011Assignee: Diopsys, Inc.Inventor: Peter H. Derr
-
Patent number: 7578795Abstract: A system and method for performing a vision examination includes displaying a series of visual stimuli for observation by a patient and detecting the patient's visual evoked potentials in response to the visual stimuli. Electrical signals representative of the visual evoked potentials for each stimulus of each series of visual stimuli displayed is amplified, converted to digitized data, recorded and measured. The measured visual evoked potential data is then evaluated and compared to certain predetermined values in order to detect whether or not the measured data is reliable. Data outside of predetermined ranges of values is considered faulty data. For example, the measured data is compared to a maximum value of the output of an amplifier used to enhance the electrical signals, to a predetermined value of the Fourier component at 60 Hz; and to certain ranges to determine if the measured data are outside of expected limits. The occurrence of such data outside these ranges is faulty data.Type: GrantFiled: August 7, 2001Date of Patent: August 25, 2009Assignee: Diopsys, Inc.Inventors: George Z. Hu, Vance Marc Zemon, Peter Derr
-
Publication number: 20060282008Abstract: A system and method for performing a vision examination includes displaying a series of visual stimuli for observation by a patient and detecting the patient's visual evoked potentials in response to the visual stimuli. Electrical signals representative of the visual evoked potentials for each stimulus of each series of visual stimuli displayed is amplified, converted to digitized data, recorded and measured. The measured visual evoked potential data is then evaluated and compared to certain predetermined values in order to detect whether or not the measured data is reliable. Data outside of predetermined ranges of values is considered faulty data. For example, the measured data is compared to a maximum value of the output of an amplifier used to enhance the electrical signals, to a predetermined value of the Fourier component at 60 Hz; and to certain ranges to determine if the measured data are outside of expected limits. The occurrence of such data outside these ranges is faulty data.Type: ApplicationFiled: August 21, 2006Publication date: December 14, 2006Applicant: DIOPSYS, INC.Inventors: George Hu, Vance Zemon, Peter Derr
-
Publication number: 20030032894Abstract: A system and method for performing a vision examination includes displaying a series of visual stimuli for observation by a patient and detecting the patient's visual evoked potentials in response to the visual stimuli. Electrical signals representative of the visual evoked potentials for each stimulus of each series of visual stimuli displayed is amplified, converted to digitized data, recorded and measured. The measured visual evoked potential data is then evaluated and compared to certain predetermined values in order to detect whether or not the measured data is reliable. Data outside of predetermined ranges of values is considered faulty data. For example, the measured data is compared to a maximum value of the output of an amplifier used to enhance the electrical signals, to a predetermined value of the Fourier component at 60 Hz; and to certain ranges to determine if the measured data are outside of expected limits. The occurrence of such data outside these ranges is faulty data.Type: ApplicationFiled: August 7, 2001Publication date: February 13, 2003Applicant: DIOPSYS, INC.Inventors: George Z. Hu, Vance Marc Zemon, Peter Derr
-
Patent number: 6475162Abstract: A system and method for performing a vision examination includes displaying a series of visual stimuli in a line by line pattern display for observation by a patient and detecting the patient's visual evoked potential in response to the visual stimuli. Electrical signals representative of the visual evoked potentials for each stimulus of each series of visual stimuli displayed is converted to digitized data, recorded and measured. The measured evoked potential data is then evaluated and compared to certain predetermined values in order to detect whether or not the measured data is reliable.Type: GrantFiled: August 7, 2001Date of Patent: November 5, 2002Assignee: Diopsys, Inc.Inventor: George Z. Hu